Apollomics (APLM) Other Non-Current Assets (2021 - 2025)
Apollomics (APLM) reported Other Non-Current Assets of $83000.0 for Q4 2025, down 30.25% quarter-over-quarter from $119000.0 in Q4 2023.
Apollomics (APLM) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Apollomics (APLM) has 4 years of Other Non-Current Assets data on file, last reported at $83000.0 in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $83000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $83000.0 (changed N/A YoY), and the FY2025 annual result was $83000.0, up 10.67% from the prior year.
- Other Non-Current Assets retreated to $83000.0 in Q4 2025 per APLM's latest filing, from $119000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $124000.0 in Q4 2022 and troughed at $83000.0 in Q4 2025.
- A 4-year average of $109750.0 and a median of $116000.0 in 2021 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets advanced 9.73% in 2022, then dropped 4.03% in 2023.
- A 4-year view of Other Non-Current Assets shows it stood at $113000.0 in 2021, then advanced by 9.73% to $124000.0 in 2022, then declined by 4.03% to $119000.0 in 2023, then slumped by 30.25% to $83000.0 in 2025.
- Business Quant data shows APLM's Other Non-Current Assets at $83000.0 in Q4 2025, $119000.0 in Q4 2023, and $124000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Apollomics | 294.00 Mn | 294.00 Mn | - | 83,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83,000.00 |
| Dec 31, 2023 | 119,000.00 |
| Dec 31, 2022 | 124,000.00 |
| Dec 31, 2021 | 113,000.00 |